Arvinas Inc (ARVN)
35.23
0.00 (0.00%)
USD |
NASDAQ |
May 24, 16:00
35.23
0.00 (0.00%)
After-Hours: 20:00
Arvinas Price to Book Value: 3.954 for May 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 3.954 |
| May 23, 2024 | 3.954 |
| May 22, 2024 | 4.035 |
| May 21, 2024 | 3.889 |
| May 20, 2024 | 3.733 |
| May 17, 2024 | 3.668 |
| May 16, 2024 | 3.604 |
| May 15, 2024 | 3.629 |
| May 14, 2024 | 3.520 |
| May 13, 2024 | 3.543 |
| May 10, 2024 | 3.529 |
| May 09, 2024 | 3.586 |
| May 08, 2024 | 3.633 |
| May 07, 2024 | 3.853 |
| May 06, 2024 | 3.621 |
| May 03, 2024 | 3.684 |
| May 02, 2024 | 3.633 |
| May 01, 2024 | 3.639 |
| April 30, 2024 | 3.559 |
| April 29, 2024 | 3.574 |
| April 26, 2024 | 3.627 |
| April 25, 2024 | 3.540 |
| April 24, 2024 | 3.646 |
| April 23, 2024 | 3.809 |
| April 22, 2024 | 3.910 |
| Date | Value |
|---|---|
| April 19, 2024 | 3.890 |
| April 18, 2024 | 3.842 |
| April 17, 2024 | 3.748 |
| April 16, 2024 | 3.746 |
| April 15, 2024 | 3.890 |
| April 12, 2024 | 4.066 |
| April 11, 2024 | 4.174 |
| April 10, 2024 | 4.115 |
| April 09, 2024 | 4.266 |
| April 08, 2024 | 4.218 |
| April 05, 2024 | 4.195 |
| April 04, 2024 | 4.246 |
| April 03, 2024 | 4.324 |
| April 02, 2024 | 4.374 |
| April 01, 2024 | 4.526 |
| March 31, 2024 | |
| March 28, 2024 | 4.258 |
| March 27, 2024 | 4.264 |
| March 26, 2024 | 4.230 |
| March 25, 2024 | 4.195 |
| March 22, 2024 | 4.322 |
| March 21, 2024 | 4.472 |
| March 20, 2024 | 4.555 |
| March 19, 2024 | 4.390 |
| March 18, 2024 | 4.394 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.707
Minimum
Oct 27 2023
19.38
Maximum
Dec 30 2020
5.213
Average
4.868
Median
Apr 20 2022
Price to Book Value Benchmarks
| Pfizer Inc | 1.773 |
| Johnson & Johnson | 5.052 |
| Bristol-Myers Squibb Co | 5.070 |
| Janux Therapeutics Inc | 3.587 |
| ACADIA Pharmaceuticals Inc | 5.412 |
Price to Book Value Related Metrics
| PS Ratio | 29.70 |
| PEG Ratio | -1.245 |
| Price | 35.23 |
| Earnings Yield | -16.83% |
| Market Cap | 2.411B |
| PEGY Ratio | -1.245 |